Acampcon 333 Tablet
By Acampcon
Rx
10 Tablet in a Strip
Composition
Acamprosate(333mg)
Manufacturer - Consern Pharma Limited
Consern Pharma Private Limited, Kuljive Mahajan(Mg. Director), Rural Focal Point, V.P.O. Tibba, Ludhiana - 141120, Punjab, India
Expires on or after
July, 2025
Caution should be exercised when using Acampcon 333 Tablet in individuals with severe liver disease. It may be necessary to adjust the dosage of the medication, so it is crucial to seek advice from your healthcare provider before starting treatment. There is limited data on the use of Acampcon 333 Tablet in individuals with liver issues, but no dose adjustment is typically required for those with mild to moderate liver disease.
Acampcon 333 Tablet should be used carefully in patients with kidney disease. A dose adjustment may be necessary, so it's important to consult your doctor. Avoid using this tablet if you have severe kidney disease.
Consult your doctor when consuming alcohol with Acampcon 333 Tablet.
Acampcon 333 Tablet typically does not impact driving ability.
Acampcon 333 Tablet may not be safe during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will consider the benefits and risks before prescribing. Please consult your doctor.
Acampcon 333 Tablet is considered safe during breastfeeding based on limited human data indicating no significant risk to the baby.
Habit Forming | No |
Chemical Class | Organosulfonic Acid |
Therapeutic Class | - |
Action Class | Alcohol deaddiction |
₹137
Inclusive of all taxes
Content verified by
Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025